BRT has been awarded the EU quality label for first-class innovation ideas worthy of investment for the project proposal 784022, MiStem, Revolutionizing Transplantation Treatment of Blood Cancers: Direct Reprogramming of Skin Cells into Blood Stem Cells, being scored as a “HIGH-QUALITY PROJECT PROPOSAL IN A HIGHLY COMPETITIVE EVALUATION PROCESS”.
